Symbol="CFRX"
AssetType="Common Stock"
Name="ContraFect Corp"
Description="ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of protein and antibody therapeutics for the treatment of drug-resistant and life-threatening infectious diseases in the United States. The company is headquartered in Yonkers, New York."
CIK="1478069"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="28 WELLS AVENUE, 3RD FLOOR, YONKERS, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5355100"
EBITDA="-49612000"
PERatio="None"
PEGRatio="0"
BookValue="-2.003"
DividendPerShare="0"
DividendYield="0"
EPS="-946.57"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.812"
ReturnOnEquityTTM="-3.452"
RevenueTTM="0"
GrossProfitTTM="-1606434"
DilutedEPSTTM="-946.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.441"
EVToRevenue="-"
EVToEBITDA="0.163"
Beta="0.419"
num_52WeekHigh="269.6"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.625"
num_200DayMovingAverage="6.53"
SharesOutstanding="3669900"
DividendDate="2020-02-04"
ExDividendDate="None"
symbol="CFRX"
open="1.45"
high="1.46"
low="1.35"
price="1.42"
volume="108307.00"
latest_trading_day="2023-07-06"
previous_close="1.43"
change="-0.01"
change_percent="-0.6993%"
aroon_positive_momentum_days="29"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="29"
Volume_recent_avg="3280810"
Change_recent_avg="-0.07"
Delta_recent_avg="0.29"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-3.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="29"
Aroon_momentum_negative="71"
image_negative_thumbnail_id_1="111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_negative_thumbnail_id_2="1127"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0160.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="696"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0012.jpeg"
image_positive_thumbnail_id_2="627"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0081.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
